Our TAZ overexpression and knockout studies in vitro and in vivo strongly suggest that TAZ is not only a driver for lung CSC formation but also essential for the maintenance of the CSC phenotype in lung cancers (Figures 1 and 6). The gene discussed is WWTR1; the disease is lung carcinoma.